Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Extraskeletal Ewing's sarcoma].

J Baram1, T Tichler, D Nass

  • 1Dept of Oncology, Chaim Sheba Medical Center, Tel Hashomer.

Harefuah
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Extraskeletal Ewing's sarcoma is a rare and aggressive cancer in adults. Early diagnosis and effective chemotherapy are crucial for improving patient outcomes.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas.

AJNR. American journal of neuroradiology·2016
Same author

Convection-enhanced drug delivery of interleukin-4 Pseudomonas exotoxin (PRX321): increased distribution and magnetic resonance monitoring.

The Journal of pharmacology and experimental therapeutics·2009
Same author

Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.

Molecular and cellular endocrinology·2008
Same author

Low electric field enhanced chemotherapy can cure mice with CT-26 colon carcinoma and induce anti-tumour immunity.

Clinical and experimental immunology·2004
Same author

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.

Bone marrow transplantation·2003
Same author

Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.

Pituitary·2002
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Area of Science:

  • Oncology
  • Sarcoma Research

Context:

  • Extraskeletal Ewing's sarcoma (EES) is a rare malignant neoplasm.
  • Adult oncology units encounter limited cases of EES.

Purpose:

  • To describe the clinical characteristics and outcomes of adult patients with EES.
  • To highlight the aggressive nature of EES and inform treatment strategies.

Summary:

  • Five adult male patients with EES were analyzed (age 18-57).
  • Tumor locations included trunk (4) and extremity (1).
  • Surgical resection was challenging; 3 patients died within 27 months, while 2 survived long-term.

Impact:

  • This study underscores the aggressive behavior of EES in adults.
  • Emphasizes the critical need for prompt diagnosis and robust chemotherapy regimens.